ライフサイエンスコーパス: vaccine preparation

1 cacy of H5N1 vaccine without modification of vaccine preparation.

2 future development of diagnostic assays and vaccine preparations.

3 fied and/or contaminating TLR ligands in PPS vaccine preparations.

4 prove to be essential components of malaria vaccine preparations.

5 e of such strains or synthetic constructs in vaccine preparations.

6 One vaccine preparation also contained cells transduced with

7 0 (40 participants); as a control, a placebo vaccine preparation also was administered (10 participan

8 l pathogenesis and host protective immunity, vaccine preparation and characteristics, stimulated host

9 those with primary responsibility for study vaccine preparation and dispensing), and investigators w

10 lecules, exosomes may also have potential in vaccine preparations and as diagnostic markers.

11 Comparative NMR analysis of different vaccine preparations and stability samples provides a gl

12 nd that immunization of rabbits with an rD15 vaccine preparation conferred partial protection against

13 HER-2/neu-overexpressing cancers received a vaccine preparation consisting of putative HER-2/neu hel

14 Previously, we showed that a vaccine preparation containing the native hemoglobin rec

15 ce with formalin-inactivated influenza virus vaccine preparations containing disparate HA and NA prot

16 ogic materials that come in contact with the vaccine preparation during production to prevent the int

17 more, inclusion of NA in addition to HA in a vaccine preparation for chickens may not enhance the hig

18 nactivated respiratory syncytial virus (RSV) vaccine preparations have been shown to cause enhanced d

19 uce the logistical demands of using separate vaccine preparations in the field.

20 Current dendritic cell (DC) vaccine preparations involving ex vivo differentiation a

21 5) vectors both expressing Ag85A in a single vaccine preparation is able to reduce anti-vector immuni

22 The incorporation of such peptides into vaccine preparations may enhance the efficacy of vaccine

23 acterial proteins through their inclusion in vaccine preparations must continue to be pursued.

24 een treated clinically with crude or defined vaccine preparations or cytokines, such as IFN-gamma and

25 Human vaccine preparation requires the use of appropriate cell

26 nt out the importance of cell substrates for vaccine preparation since the virus may change during pa

27 prior infection and 2 Aspergillus fumigatus vaccine preparations (sonicate and filtrate) administere

28 aride (LPS) and assessed the ability of each vaccine preparation to protect mice against pulmonary ch

29 evelopment of a standardized anti-RNP T cell vaccine preparation useful for multiple patients.

30 rticipants and study staff not involved with vaccine preparation were masked to the randomisation gro

31 terns of mutations present at a low level in vaccine preparations were characteristic of seed viruses